SCHEMBL11255890

SCHEMBL11255890

CC(Cc1ccc(OCC(=O)[O-])cc1)NCC(O)c1ccccc1.[Na+]

nearest known ligand 0.77

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 16/20 0.77
ADRB2 P07550 12/20 0.77
CYP2D6 P10635 2/20 0.77
CYP3A4 P08684 1/20 0.77
HIF1A Q16665 1/20 0.77
ADRB1 P08588 13/20 0.64
ADRA1D P25100 1/20 0.64
ADRA1A P35348 1/20 0.64
ADRA1B P35368 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
GLA P06280 1/20 0.60
SLC2A1 P11166 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10478199 0.90 ADRB3 (0.78) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL11255869 0.88 ADRB3 (0.77) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL22729973 0.87 ADRB3 (1.00) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL6678497 0.87 ADRB3 (1.00) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL11251142 0.87 ADRB3 (0.77) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL11247530 0.87 ADRB3 (0.77) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL11253857 0.87 ADRB3 (0.77) ADRB3ADRB2CYP2D6CYP3A4HIF1A
Water SCHEMBL15421413 0.87 ADRB3 (0.98) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL11245796 0.86 ADRB3 (0.65) ADRB3ADRB2CYP2D6CYP3A4HIF1A
SCHEMBL7153650 0.82 ADRB2 (0.62) ADRB3ADRB2CYP2D6ADRB1ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4338333-A ANTIOBESITY, HYPOGLYCEMIC BEECHAM GROUP LIMITED (GB) 1982-07-06 US claimed
EP-0023385-A1 Ethanamine derivatives, their preparation and use in pharmaceutical compositions BEECHAM GROUP PLC (GB) 1981-02-04 EP disclosed